11 March 2016

mRNA Therapies: Now and Next

Organised by:

SCI's Biotechnology Group in partnership with the University of Westminster

University of Westminster

Registration Closed

This event is no longer available for registration.

Synopsis

mRNA therapies have attracted significant interest in the last few years. CureVac has been active in this field for over 15 years and has applied its mRNA platform to cancer immunotherapy and prophylactic vaccines, and is now exploring the immense potential of molecular therapy. Dr Horschcroft will presen some of his CureVac's preclincal data and give a glimpse of where they are heading next.

Programme

Day 1 - 11 March 2016

Event Schedule

13:00: Event starts

Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

University of Westminster

School of Life Sciences
115 New Cavendish Street
London W1W 6UW

SCI Communications Team

Tel: +44 (0) 20 7598 1594

Email: communications@soci.org

Fees

This is a free event, no need to book. Please check this page for any updates or changes before attending the event.

Become an SCI Member and save on this and future events

See Membership Options